Are your patients with
diffuse large B-cell
lymphoma (DLBCL)
eligible for a Phase III
clinical trial?
diffuse large B-cell
lymphoma (DLBCL)
eligible for a Phase III
clinical trial?
An investigational
antibody-drug
conjugate for DLBCL
antibody-drug
conjugate for DLBCL
Learn more
about a Phase III clinical
trial in aggressive
B-cell lymphoma
about a Phase III clinical
trial in aggressive
B-cell lymphoma